Last week saw the signature of an agreement between Cytek Biosciences, Inc., a leading cell analysis solutions company from the US, and the Centre for Genomic Regulation (CRG) and the Pompeu Fabra University (UPF) at the Barcelona Biomedical Research Park (PRBB).
Under the terms of the agreement, Cytek will provide the CRG-UPF Flow Cytometry Unit with a new, state-of-the-art spectral cytometry platform – along with two trained support personnel.
The joint unit, founded in 2001 and based in the PRBB, is already a worldwide reference site for advanced flow cytometry applications. With this new machine, which will test an innovative technology, the unit will advance even more to facilitate research and drive technological innovation, accelerating our understanding of cell biology, immunotherapy, and targeted therapeutic methodologies.
“This collaboration is a recognition of the immense value of the cutting-edge methodologies developed by our Unit”
Oscar Fornas, head of the joint CRG-UPF Flow Cytometry Unit
Flow cytometry is a technique used to measure and analyze the physical and chemical characteristics of cells as they move through lasers. It allows to characterise, identify, count and sort cells according to different biomarkers.
The new Cytek machine is the first commercialized fluorescence-based flow cytometry platform to achieve 40 colors (i.e. able to look at 40 biomarkers at the same time) – something that was impossible until now.
The perfecgt location
Ming Yan, CTO of Cytek Biosciences, talks about the decision to choose the CRG-UPF Flow citometry unit at the PRBB to test this new techcnology.
“With the presence of several institutes working in life sciences within a unique research campus, the PRBB offers a great diversity of research fields and best-in-class technologies”
Ming Yan, CTO of Cytek Biosciences
“The integration of these institutes through shared core facilities that facilitate collaborations and promote the exchange of knowledge between scientists is a great opportunity for Cytek to guide future developments”, explains Cytek’s senior executive.
